Apr 16 |
Incannex Healthcare Inc. Quarterly Update, Q1 2024
|
Feb 28 |
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Feb 28 |
Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder
|
Feb 16 |
Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation
|
Feb 1 |
Clarion Clinics Open for Psychedelic-Assisted Treatments
|
Jan 27 |
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
|
Jan 24 |
Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis
|
Jan 12 |
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
|
Jan 7 |
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
|
Dec 22 |
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
|